Dihydroergotamine

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51142400
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51142404

This classification denotes a nonnarcotic analgesic and dopamine agonist with the molecular formula C33H37N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 436O5HM03C, chemically known as ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5.alpha.,10.alpha.)-, monomethanesulfonate but generally known as dihydroergotamine, which bears US NIH Compound Identifier 3066. European Medicines Agency schedules Dihydroergotamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07139MIG. The term DIHYDROERGOTAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules dihydroergotamine in its Anatomical Therapeutic Chemical (ATC) Classification. DIHYDROERGOTAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dihydroergotamine under HS 29396900 and SITC 54146. As of Q4 2014, DIHYDROERGOTAMINE remains the US FDA Preferred Term for this commodity. Dihydroergotamine bears US NLM identifiers UMLS ID C0012291 and NCI Concept Code C65387. SMILES: O1C2(O)N(C(C(=O)N3C2CCC3)CC2CCCCC2)C(=O)C1(NC(=O)C1CC2C(N(C1)C)CC1C3C2CCCC3[NH]C1)C.

Same parent

Under 51142400 · 29

51142401 Methysergide Commodity 51142404 Dihydroergotamine You are here 51142405 Combination acetaminophen acetylsalicylic acid Commodity 51142408 Frovatriptan Commodity 51142411 Rizatriptan Commodity 51142412 Eletriptan Commodity 51142413 Zolmitriptan Commodity 51142414 Sumatriptan Commodity 51142415 Combination acetaminophen butalbital Commodity 51142416 Iprazochrome Commodity 51142417 Almotriptan Commodity 51142418 Donitriptan Commodity 51142419 Dotarizine Commodity 51142420 Ergotamine Commodity 51142421 Naratriptan Commodity 51142422 Oxetorone Commodity 51142423 Almotriptan malate Commodity 51142424 Dihydroergotamine mesilate or mesylate Commodity 51142425 Dihydroergotamine methanesulfonate Commodity 51142426 Donitriptan hydrochloride Commodity 51142427 Eletriptan hydrobromide Commodity 51142428 Ergotamine tartrate Commodity 51142429 Frovatriptan succinate Commodity 51142430 Frovatriptan succinate hydrate Commodity 51142431 Methysergide maleate Commodity 51142432 Naratriptan hydrochloride Commodity 51142433 Rizatriptan benzoate Commodity 51142434 Rizatriptan sulfate Commodity 51142435 Sumatriptan succinate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51140000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.